ABSTRACT
The hepatitis C virus (HCV) has an alternate reading frame (ARF) that overlaps the
core protein gene. The overlapping reading frame distinguishes HCV from all of its
known viral relatives, with the possible exception of GB virus B (GBV-B). The ARF
is expressed during natural HCV infections and stimulates specific immune responses.
Like several essential genes in other viruses (e.g., the human immunodeficiency virus
polymerase) the ARF lacks an in-frame AUG start codon, suggesting that its expression
involves unusual translation-level events. In vitro studies indicate that ribosomal
frameshifting may be one of several processes that can lead to translation of the
ARF. Frameshifting yields chimeric proteins that have segments encoded in the core
gene covalently attached to amino acids encoded in the ARF. A consistent nomenclature
for the ARF's protein products has yet to be established. We propose that all proteins
that contain amino acids encoded in the + 1 ARF be called alternate reading frame
proteins (ARFPs) and that specific ARFPs, such as the ARFP/F-protein, the double-frameshift
protein, and the short form of core + 1, be designated as follows: ARFP/F (ARFP/F-protein),
ARFP/DF (double-frameshift), and ARFP/S (short form of core + 1). The roles of ARFPs
in the HCV life cycle are not yet known. There is a significant possibility that ARFPs
may be responsible for some of the effects attributed to the core protein, given that
most studies seeking to define the function of the core protein have employed materials
likely to contain a combination of the core protein and ARFPs. The observed effects
of the core protein include the induction of liver cancer, transformation of cells,
and alterations of immune responses. This article reviews the discovery of ARF, describes
the RNA structural elements involved in core/ARF gene expression, discusses possible
functions of ARFPs, and considers the potential usefulness of ARFPs in vaccines. The
HCV ARF is the focus of a new and rapidly expanding area of research, and the results
of many ongoing studies are currently available in abstract form only. The preliminary
nature of investigations that have not yet been reviewed by peers is noted in the
text.
KEYWORDS
Hepatitis C - alternate reading frame - ARFP - F-protein - frameshift - core
REFERENCES
1
Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis
genome.
Science.
1989;
244
359-362
2
Bradley D W, Cook E H, Maynard J E et al..
Experimental infection of chimpanzees with antihemophilic (factor VIII) materials:
recovery of virus-like particles associated with non-A, non-B hepatitis.
J Med Virol.
1979;
3
253-269
3
Choo Q, Richman K H, Han J H et al..
Genetic organization and diversity of the hepatitis C virus.
Proc Natl Acad Sci USA.
1991;
88
2451-2455
4
Lai M MC, Ware C F.
Hepatitis C virus core protein: possible roles in viral pathogenesis.
Curr Top Microbiol Immunol.
2000;
242
117-134
5
Ray R B, Lagging L M, Meyer K, Ray R.
Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo
fibroblasts to tumorigenic phenotype.
J Virol.
1996;
70
4438-4443
6
Moriya K, Nakagawa K, Santa T et al..
Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated
hepatocarcinogenesis.
Cancer Res.
2001;
61
4365-4370
7
Lerat H, Honda M, Beard M R et al..
Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural
proteins of hepatitis C virus.
Gastroenterology.
2002;
122
352-365
8
Hsieh T Y, Matsumoto M, Chou H C et al..
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein
K.
J Biol Chem.
1998;
273
17651-17659
9
Chang J, Yang S H, Cho Y G, Hwang S B, Hahn Y S, Sung Y C.
Hepatitis C virus core from two different genotypes has an oncogenic potential but
is not sufficient for transforming primary rat embryo fibroblasts in cooperation with
the H-ras oncogene.
J Virol.
1998;
72
3060-3065
10
Jin D Y, Wang H L, Zhou Y et al..
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular
transformation.
EMBO J.
2000;
19
729-740
11
Tai D I, Tsai S L, Chen Y M et al..
Activation of nuclear factor kappaB in hepatitis C virus infection: implications for
pathogenesis and hepatocarcinogenesis.
Hepatology.
2000;
31
656-664
12
Lee S, Park U, Lee Y I.
Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription
through acting concurrently on Egr1 and Sp1 sites.
Virology.
2001;
283
167-177
13
Yoshida T, Hanada T, Tokuhisa T et al..
Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.
J Exp Med.
2002;
196
641-653
14
McLauchlan J.
Properties of the hepatitis C virus core protein: a structural protein that modulates
cellular processes.
J Viral Hepat.
2000;
7
2-14
15
Basu A, Meyer K, Ray R B, Ray R.
Hepatitis C virus core protein is necessary for the maintenance of immortalized human
hepatocytes.
Virology.
2002;
298
53-62
16
Delhem N, Sabile A, Gajardo R et al..
Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma
derived-hepatitis C virus core protein.
Oncogene.
2001;
20
5836-5845
17
Soguero C, Joo M, Chianese-Bullock K A, Nguyen D T, Tung K, Hahn Y S.
Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic
murine model.
J Virol.
2002;
76
9345-9354
18
Dolganiuc A, Oak S, Kodys K et al..
Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated
pathways and inflammatory activation.
Gastroenterology.
2004;
127
1513-1524
19
Aguilar J C, Acosta-Rivero N, Duenas-Carrera S et al..
HCV core protein modulates the immune response against the HBV surface antigen in
mice.
Biochem Biophys Res Commun.
2003;
310
59-63
20
Eisen-Vandervelde A L, Waggoner S N, Yao Z Q, Cale E M, Hahn C S, Hahn Y S.
Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages
by interfering with AP-1 activation.
J Biol Chem.
2004;
279
43479-43486
21
Erhardt A, Hassan M, Heintges T, Haussinger D.
Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK,
and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 tet-off
cell line.
Virology.
2002;
292
272-284
22
Brown E A, Zhang H, Ping L H, Lemon S M.
Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus
genomic RNAs.
Nucleic Acids Res.
1992;
20
5041-5045
23
Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A.
Internal ribosome entry site within hepatitis C virus RNA.
J Virol.
1992;
66
1476-1483
24
Wang C, Sarnow P, Siddiqui A.
Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal
ribosome-binding mechanism.
J Virol.
1993;
67
3338-3344
25
Spahn C M, Kieft J S, Grassucci R A et al..
Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal
subunit.
Science.
2001;
291
1959-1962
26
Kolykhalov A A, Feinstone S M, Rice C M.
Identification of a highly conserved sequence element at the 3′ terminus of hepatitis
C virus genome RNA.
J Virol.
1996;
70
3363-3371
27
Kolykhalov A A, Mihalik K, Feinstone S M, Rice C M.
Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′
nontranslated region are essential for virus replication in vivo.
J Virol.
2000;
74
2046-2051
28
Walewski J L, Stump D D, Keller T R, Branch A D.
HCV patients have antibodies against a novel protein encoded in a second reading frame.
Hepatology.
1998;
28
278A
29
Walewski J L, Keller T R, Stump D D, Branch A D.
Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.
RNA.
2001;
7
710-721
30
Xu Z, Choi J, Yen T S et al..
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift.
EMBO J.
2001;
20
3840-3848
31
Vassilaki N, Mavromara P.
Two alternative translation mechanisms are responsible for the expression of the HCV
ARFP/F/core + 1 coding open reading frame.
J Biol Chem.
2003;
278
40503-40513
32
Boulant S, Becchi M, Penin F, Lavergne J P.
Unusual multiple recoding events leading to alternative forms of hepatitis C virus
core protein from genotype 1b.
J Biol Chem.
2003;
278
45785-45792
33
Komurian-Pradel F, Rajoharison A, Berland J L et al..
Antigenic relevance of F protein in chronic hepatitis C virus infection.
Hepatology.
2004;
40
900-909
34 Miladi A, Lavergne J, Hezode C, Dhumeaux D, Penin F, Pawlotsky J M. Prevalence
of anti-HCV F (frameshift) protein antibodies in patients with various forms of HCV
infection and the putative physiological role of F protein. Paper presented at: 11th
International Symposium on Hepatitis C Virus and Related Viruses abstract P-257 October
3-7, 2004 in Heidelberg, Germany;
35
Bain C, Parroche P, Lavergne J P et al..
Memory T-cell-mediated immune responses specific to an alternative core protein in
hepatitis C virus infection.
J Virol.
2004;
78
10460-10469
36
Ina Y, Mizokami M, Ohba K, Gojobori T.
Reduction of synonymous substitutions in the core protein gene of hepatitis C virus.
J Mol Evol.
1994;
38
50-56
37
Smith D B, Simmonds P.
Characteristics of nucleotide substitutions in the hepatitis C virus genome: constraints
on sequence change in coding regions at both ends of the genome.
J Mol Evol.
1997;
45
238-246
38
Walewski J L, Gutierrez J A, Branch-Elliman W et al..
Mutation master: profiles of substitutions in hepatitis C virus RNA of the core, alternate
reading frame, and NS2 coding regions.
RNA.
2002;
8
557-571
39
James B D, Olsen G J, Pace N R.
Phylogenetic comparative sequence analysis of RNA secondary structure.
Methods Enzymol.
1989;
180
227-239
40
James B D, Olsen G J, Pace N R.
Phylogenic comparative analysis of RNA secondary structure.
Methods Enzymol.
1989;
180
227-239
41
Zuker M, Stiegler P.
Optimal computer folding of large RNA sequences using thermodynamics and auxiliary
information.
Nucleic Acids Res.
1981;
9
133-148
42
You S Y, Stump D D, Branch A D, Rice C M.
A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA
polymerase is required for hepatitis C virus RNA replication.
J Virol.
2004;
78
1352-1366
43
Lee H, Shin H, Wimmer E, Paul A V.
cis-Acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus
genome.
J Virol.
2004;
78
10865-10877
44 Friebe P, Boudet J, Dimorre J P, Bartenschlager R. A kissing loop interaction between
a novel cis acting RNA element in the NS5b coding region and the 3′ non-translated
region is required for hepatitis C virus RNA replication. Paper presented at: 11th
International Symposium on Hepatitis C Virus and Related Viruses abstract 0-17 October
3-7, 2004 in Heidelberg, Germany;
45
Gesteland R F, Weiss R B, Atkins J F.
Recoding: reprogrammed genetic decoding.
Science.
1992;
257
1640-1641
46
Matsufuji S, Matsufuji T, Miyazaki Y et al..
Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme.
Cell.
1995;
80
51-60
47
Ivanov I P, Gesteland R F, Atkins J F.
A second mammalian antizyme: conservation of programmed ribosomal frameshifting.
Genomics.
1998;
52
119-129
48
Weiss R B, Dunn D M, Dahlberg A E, Atkins J F, Gesteland R F.
Reading frame switch caused by base-pair formation between the 3′ end of 16S rRNA
and the mRNA during elongation of protein synthesis in Escherichia coli
.
EMBO J.
1988;
7
1503-1507
49
Dulude D, Baril M, Brakier-Gingras L.
Characterization of the frameshift stimulatory signal controlling a programmed -1
ribosomal frameshift in the human immunodeficiency virus type 1.
Nucleic Acids Res.
2002;
30
5094-5102
50
Varaklioti A, Vassilaki N, Georgopoulou U, Mavromara P.
Alternate translation occurs within the core coding region of the hepatitis C viral
genome.
J Biol Chem.
2002;
277
17713-17721
51
Gosert R, Moradpour D.
Reading between the lines: evidence for a new hepatitis C virus protein.
Hepatology.
2002;
36
757-760
52
Choi J, Xu Z, Ou Jh.
Triple decoding of hepatitis C virus RNA by programmed translational frameshifting.
Mol Cell Biol.
2003;
23
1489-1497
53
Roussel J, Pillez A, Montpellier C et al..
Characterization of the expression of the hepatitis C virus F protein.
J Gen Virol.
2003;
84
1751-1759
54
Basu A, Meyer K, Ray R B, Ray R.
Hepatitis C virus core protein is necessary for the maintenance of immortalized human
hepatocytes.
Virology.
2002;
298
53-62
55
Lo S Y, Masiarz F, Hwang S B, Lai M M, Ou J H.
Differential subcellular localization of hepatitis C virus core gene products.
Virology.
1995;
213
455-461
56
Lo S Y, Selby M, Tong M, Ou J H.
Comparative studies of the core gene products of two different hepatitis C virus isolates:
two alternative forms determined by a single amino acid substitution.
Virology.
1994;
199
124-131
57
Xu Z, Choi J, Lu W, Ou J H.
Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic
reticulum.
J Virol.
2003;
77
1578-1583
58 Wolf M, Dimitrova M, Kien F, Schuster C. Translocation of the hepatitis C virus
F protein sequence: influence of the RNA context and of the presence of HCV proteins. Paper
presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses
abstract P-84 October 3-7, 2004 in Heidelberg, Germany;
59 Vassilaki N, Mavromara P. Expression studies on the short form of the HCV ARFP/F/core
+ 1 protein in mammalian cells. Paper presented at: 11th International Symposium on
Hepatitis C Virus and Related Viruses abstract 0-25 October 3-7, 2004 in Heidelberg,
Germany;
60
Ganem D.
Virology. The X files-one step closer to closure.
Science.
2001;
294
2299-2300
61
Lohmann V, Korner F, Koch J O, Herian U, Theilmann L, Bartenschlager R.
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
Science.
1999;
285
110-113
62
Blight K J, Kolykhalov A A, Rice C M.
Efficient initiation of HCV RNA replication in cell culture.
Science.
2000;
290
1972-1974
63 McMulllan L K, Grakoui A, Puig M et al.. Multiple stop codons in the HCV ARF suggest
that expression of F/ARFP is not essential for virus replication but reveal a functional
RNA element. Paper presented at: 11th International Symposium on Hepatitis C Virus
and Related Viruses abstract 0-20 October 3-7, 2004 in Heidelberg, Germany;
64
Bukh J, Miller R H, Purcell R H.
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.
Semin Liver Dis.
1995;
15
41-63
65
Shimizu I, Yao D-F, Horie C et al..
Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients
with hepatocellular carcinoma in China.
J Gastroenterol.
1997;
32
47-55
66
Takahashi K, Iwata K, Matsumoto M et al..
Hepatitis C virus (HCV) genotype 1b sequences from fifteen patients with hepatocellular
carcinoma: the ‘progression score’ revisited.
Hepatol Res.
2001;
20
161-171
67
Hayashi J, Furusyo N, Ariyama I, Sawayama Y, Etoh Y, Kashiwagi S.
A relationship between the evolution of hepatitis C virus variants, liver damage,
and hepatocellular carcinoma in patients with hepatitis C viremia.
J Infect Dis.
2000;
181
1523-1527
68
Ruster B, Zeuzem S, Krump-Konvalinkova V et al..
Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from
tumor and adjacent non-tumor tissue.
J Med Virol.
2001;
63
128-134
69
Alam S S, Nakamura T, Naganuma A et al..
Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the
core protein-encoding region.
Acta Med Okayama.
2002;
56
141-147
70
Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H.
Comparative sequence analysis of the core protein and its frameshift product, the
F protein, of hepatitis C virus subtype 1b strains obtained from patients with and
without hepatocellular carcinoma.
J Clin Microbiol.
2002;
40
3625-3630
71
Yeh C T, Lo S Y, Dai D I, Tang J H, Chu C M, Liaw Y F.
Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to
the synthesis of a short core protein product.
J Gastroenterol Hepatol.
2000;
15
182-191
72
Rullier A, Trimoulet P, Urbaniak R et al..
Immunohistochemical detection of HCV in cirrhosis, dysplastic nodules, and hepatocellular
carcinomas with parallel-tissue quantitative RT-PCR.
Mod Pathol.
2001;
14
496-505
73
Branch A D, Walewski J L, Gutierrez J A et al..
HCV alternate reading frame proteins (ARFPs) may be virulence factors that help the
virus survive adverse conditions.
Hepatology.
2003;
38
468A-469A
74
Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell G A, Lemon S M.
Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed
translation.
Gastroenterology.
2000;
118
152-162
75
Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R.
Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.
J Virol.
2001;
75
1252-1264
76
Basu A, Steele R, Ray R, Ray R B.
Functional properties of a 16 kDa protein translated from an alternative open reading
frame of the core-encoding genomic region of hepatitis C virus.
J Gen Virol.
2004;
85
2299-2306
77
Griffin S V, Shankland S J.
Not just an inhibitor: a role for p21 beyond the cell cycle-The truth is rarely pure
and never simple.
J Am Soc Nephrol.
2004;
15
825-826
78
Coqueret O.
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?.
Trends Cell Biol.
2003;
13
65-70
79
Shou J, Soriano R, Hayward S W, Cunha G R, Williams P M, Gao W Q.
Expression profiling of a human cell line model of prostatic cancer reveals a direct
involvement of interferon signaling in prostate tumor progression.
Proc Natl Acad Sci USA.
2002;
99
2830-2835
80
Kulaeva O I, Draghici S, Tang L, Kraniak J M, Land S J, Tainsky M A.
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization.
Oncogene.
2003;
22
4118-4127
81 Zhang X, Chatel L, Fournillier A et al.. Vaccine induced immune responses specific
of the Alternate Reading Frame Protein (ARFP) of HCV. Paper presented at: 11th International
Symposium on Hepatitis C Virus and Related Viruses abstract 0-68 October 3-7, 2004
in Heidelberg, Germany;
82
Malarkannan S, Horng T, Shih P P, Schwab S, Shastri C.
Presentation of out-of-frame peptide/MHC class I complexes by a novel translation
initiation mechanism.
Immunity.
1999;
10
681-690
83
Cardinaud S, Moris A, Fevrier M et al..
Identification of cryptic MCHI-restricted epitopes encoded by HIV-1 alternate reading
frames.
J Exp Med.
2004;
199
1053-1063
84
André P, Perlemuter G, Budkowska A, Bréchot C, Lotteau V.
Hepatitis C virus particles and lipoprotein metabolism.
Semin Liver Dis.
2005;
25
93-104
85
Tillmann H L, Manns M P, Rudolph K L.
Merging models of hepatitis C virus pathogenesis.
Semin Liver Dis.
2005;
25
84-92
86
Heller T, Rehermann B.
Acute hepatitis C: A multifaceted disease.
Semin Liver Dis.
2005;
25
7-17
87
Morgello S.
The nervous system and hepatitis C virus.
Semin Liver Dis.
2005;
25
118-121
Andrea D BranchM.D.
Division of Liver Diseases, Mount Sinai School of Medicine
New York, NY 10029
Email: andrea.branch@mssm.edu